General Partner Inc’s AbbVie ABBV Stock Holding History

General Partner Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$514K	Hold	2,044	–	–	0.28%	62
2026 Q1	$445K	Hold	2,044	–	–	0.27%	59
2025 Q4	$467K	Hold	2,044	–	–	0.26%	57
2025 Q3	$473K	Hold	2,044	–	–	0.26%	59
2025 Q2	$379K	Hold	2,044	–	–	0.22%	65
2025 Q1	$428K	Hold	2,044	–	–	0.28%	57
2024 Q4	$363K	Hold	2,044	–	–	0.22%	66
2024 Q3	$404K	Hold	2,044	–	–	0.25%	63
2024 Q2	$351K	Buy	2,044 +2	+0.1%	+$331	0.22%	65
2024 Q1	$372K	Buy	2,042 +1,792	+717%	+$309K	0.23%	67
2023 Q4	$38.7K	Hold	250	–	–	0.03%	94
2023 Q3	$37.3K	Hold	250	–	–	0.03%	97
2023 Q2	$33.7K	Hold	250	–	–	0.03%	100
2023 Q1	$40.4K	Buy	+250	New	+$38.2K	0.04%	99

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

General Partner Inc's ABBV Position: Q2 2026 in Review

General Partner Inc held its AbbVie (ABBV) position steady in Q2 2026 at 2,044 shares worth $514K. The position accounts for 0.28% of the portfolio, ranked #62.

General Partner Inc first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 921 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

General Partner Inc held 2,044 shares of AbbVie worth $514K as of Q2 2026.
General Partner Inc left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.28% of General Partner Inc's portfolio in Q2 2026, its #62 holding.
General Partner Inc first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
921 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on General Partner Inc's 13F filing for Q2 2026, filed 6 Jul 2026.